Psychedelic Research

Less than a month after the FDA rejected MDMA for PTSD treatment, and days after the agency set a September meeting to discuss psychedelic and other treatments for PTSD, the Multidisciplinary Association for Psychedelic Studies (MAPS) awarded a $200,000 grant to Emory University researchers for a...

A recent study conducted by researchers from the University of Liège in Belgium and Imperial College London has revealed striking similarities between the altered states of consciousness experienced during near-death events and those induced by psychedelic drugs. Near-death experiences are more...

A groundbreaking study published in Scientific Reports offers the most comprehensive analysis yet of how classic psychedelics, such as LSD and psilocybin, and the drug MDMA (commonly known as ecstasy) impact cognitive functions during and after use. As PsyPost reported, the research reveals that...

Although LSD is best known for its hallucinogenic effects, a recent research published in Heliyon is sparking interest in its potential therapeutic applications. This study explores how LSD could influence the way the brain processes pain, breaking new ground for research in cognitive science and...

In a significant development in the field of psychedelic medicine, the journal Psychopharmacology has retracted three research papers on MDMA-assisted therapy due to what it described as unethical conduct at one of the study sites. As New York Times reported, the retraction has cast a shadow over...

Researchers at the University of California Davis have developed a groundbreaking tool to swiftly track neurons and biomolecules activated by psychedelic drugs. This non-invasive method, called CaST for Ca2+-activated Split-TurboID, has been described in research recently published in Nature...

As reported in a recent press release, Incannex Healthcare Inc. (NASDAQ:IXHL) has received approval from the U.S. Food and Drug Administration to proceed with a phase 2 clinical trial investigating its psilocybin formulation, PSX-001, combined with psychotherapy for treating generalized anxiety...

Welcome to Benzinga's psychedelics headlines roundup. This is our pick of must-read news items concerning the last few days of January and the first two weeks of February 2024. See previous edition: Anti-inflammatory Effects, Global Drug Survey, ‘Synthetic Surprise,’ UK’s Harm...

A new study suggests a potential link between the use of psychedelics like magic mushrooms and LSD and improved sexual function up to six months after they have been consumed. Believed to be the first scientific research into the effects of psychedelics on sex, the new findings combine responses...

West Coast’s New Psychedelics & Neurotherapeutics Institute The University of California (UC) Davis launched the Institute for Psychedelics and Neurotherapeutics to further knowledge of how psychedelics work and produce safe and effective treatments for a range of mental...

Psychedelic Research & Fed Funding By The National Institute Of Mental Health The National Institute of Mental Health (NIMH) named the types of psychedelics studies to which it would grant funds and further guidance for pre-clinical research and studies with young participants. NIMH’...

The Multidisciplinary Association for Psychedelic Studies (MAPS) has shared details for its Psychedelic Science 2023 event taking place next June 19 to 23 in Denver, Colorado.  Expecting more than 10,000 attendees, acclaimed speakers and numerous sponsors, the summer conference...

LSD Research Ramps Up: Full-Dose & Microdosing For Alzheimer's Studies Led By Beckley Foundation Coming Soon The Beckley Foundation and its founder Amanda Feilding announced a new research program with King's College London and UCL on the effects of full dose LSD as well as a...

This article by Jennifer Walker-Journey was originally published on Psychedelic Spotlight, and appears here with permission. The University of California, San Francisco (UCSF) is creating a Neuroscape Psychedelics Division, a multidisciplinary research center to bridge the gap...